Intervention
Dapagliflozin 10 mg/day
Intervention
Emerging
Unclear
1 study · 1 RCT
Outcome
Homeostatic Model Assessment of Beta-cell function (HOMA-β)
Outcome
Evidence Question
Does Dapagliflozin 10 mg/day improve Homeostatic Model Assessment of Beta-cell function (HOMA-β)?
Related to: Beta-Cell FunctionShort answer
Dapagliflozin 10 mg/day appears to improve Homeostatic Model Assessment of Beta-cell function (HOMA-β).
How the evidence connects
Each connection shows the published evidence classification for that intervention and outcome relationship.
Why do we say this?
The directional finding currently comes from one supporting study, so the evidence base remains limited and the finding should be interpreted cautiously.